314.367.1181
800.888.0011
Upcoming Studies
PRELUDE (formerly called CNTO or stem cell.)  The IP is not stem cell, but derived from umbilical cord stem cells.

A Phase 2b, Multicenter, Double-masked, Randomized Study Evaluating the Safety and Clinical Response of Subretinal Administration of CNTO 2476 in Subjects with Visual Acuity Impairment Associated with Geographic Atrophy Secondary to Age Related Macular Degeneration


SAPPHIRE (Clearside RVO)

A randomized, masked, controlled trial to study the safety and efficacy of suprachoroidal CLS-TA in conjuction with intravitreal aflibercept in subjects with Retinal Vein Occlusion

Website Builder